gabexate has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Camostat-fed rats gained less weight or lost weight, although they consumed more food than the control rat when food intake was adjusted for body weight." | 3.73 | Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats. ( Jia, D; Otsuki, M; Taguchi, M, 2005) |
| "Pyogenic osteomyelitis is often accompanied by diabetes, but the disease in the clavicula has rarely been reported." | 1.30 | Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus. ( Kasamatsu, Y; Kondo, M; Nagata, H; Nakamura, Y; Yokoo, S; Yoshida, T; Yoshioka, K, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, D | 1 |
| Taguchi, M | 1 |
| Otsuki, M | 1 |
| Green, GM | 1 |
| Guan, D | 1 |
| Schwartz, JG | 1 |
| Phillips, WT | 1 |
| Yoshioka, K | 1 |
| Nagata, H | 1 |
| Nakamura, Y | 1 |
| Kasamatsu, Y | 1 |
| Yokoo, S | 1 |
| Yoshida, T | 1 |
| Kondo, M | 1 |
3 other studies available for gabexate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Eating; Esters; Fast | 2005 |
Accelerated gastric emptying of glucose in Zucker type 2 diabetic rats: role in postprandial hyperglycaemia.
Topics: Animals; Cholecystokinin; Diabetes Mellitus, Type 2; Esters; Gabexate; Gastric Emptying; Glucose; Gu | 1997 |
Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Clavicle; Diabetes Mellitus, Type 2; Dis | 1997 |